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SUMMARY: A PI phage clone containing the near complete protein coding region of 
the human histo-blood group ABO gene locus was isolated and characterized. The 
insert was estimated at « 41 kp, and an « 20 kbp BamHI fragment contained the near 
complete coding region as evaluated by Southern blot analysis. Intron/exon 
boundaries were determined and the coding region was found to span at least seven 
exons. In situ hybridization to metaphase chromosomes confirmed the predicted
localization to 9q34. © 1995 Academic Press, Inc*
The histo-blood group ABO system is one of the major allogeneic antigen 
systems in man. The chemistry, biosynthesis, and molecular genetics have been 
established (1-3). Recent work involving isolation of the blood group A 
glycosyltransferase and cDNA cloning of ABO alleles has confirmed that the A and B 
glycosyltransferases are alleles encoded by the ABO locus (4,5). The polymorphism 
involved in the ABO blood group system including that of rare subgroups has been 
found to represent minute structural changes in the coding region of the ABO alleles 
(for a recent review see (6 )).
Here we present the genomic structure of the coding region of the ABO locus
and confirm by in situ hybridization to metaphase chromosomes the localization to 
9q34.
MATERIAL AND METHODS
Isolation and characterization o f  a  genom ic P I  phage clone:
(DuPont Merck Pharmaceutical ComDanv Human Forskin
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screened using PCR primers FY57/FY46 (7) and a single positive clone DMPC- 
HFF#1-0529F4 was obtained (Custom Service Genome System Inc.) Plasmid DNA 
was prepared according to the supplyer. The PI DNA was partly sequenced by use of 
sense and antisense primers located in the coding region of the ABO locus. Double 
stranded sequencing was performed using a modified Perkin-Elmer cycle-sequencing 
kit on a model 480 thermocycler (Perkin-Elmer). Intron sizes were determined by 
PCR amplification using flanking primers followed by hybridization with specific 
probes to the intron products.
Expression o f  A  transferase in Sf9 cells: The putative soluble A transferase gene was 
produced by RT-PCR of poly(A)+ RNA from gastric cancer cell line MKN45 using
the primers EPB83/EPB90 (5-TCGAATTCGCCCCAGAAGTCTAATGCCAG and 
5-TCGAATTCTGGCAGCCGCTCACGGGTTCC) located in exon III and VII, 
respectively (7). The DNA was cloned into the EcoRI site of pT7T3U19 (Pharmacia), 
followed by subcloning into the EcoRI site of the baculovirus transfer vector 
pACGP67. Plasmid pACGP67-A-transferase was cotransfected with purified baculo- 
Gold DNA (PharMingen) and recombinant baculovirus was obtained by three 
successive amplifications in Sf9 cells according to PharMingen’s protocol. Blood group 
A enzyme activity in the culture medium was assayed as previously described using 2- 
fucosyllactose as acceptor substrate and UDP-[14C]-GalNAc as donor substrate (4). 
Controls included noninfected cells and cells infected with a construct containing 
UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase T2 (unpublished). 
RT-PCR analysis o f  A B O  gene transcripts in hum an organs: RT-PCR was performed
using primers EPB79/EPB88 (5-ACGAATTCTACTTGTTCAGGTGGCTCTCGTC 
and 5-TCGAATTCATGGCCGAGGTGTTGCGGAC) located in exons I and VII 
respectively, of which EPB79 was used as RT primer (RT-PCR kit, Perkin-Elmer). 
PCR products were probed with an exon VII specific probe EPB77 
(5-CTCCGCTGTTCGGCACC) (Fig. 3, panel A).
In situ hybridization to metaphase chrom osom es: PI DNA was labeled with biotin-14- 
dATP using the bio-NICK system (Life Technologies). The labeled DNA was precipi­
tated with ethanol in the presence of herring sperm DNA. Precipitated DNA was 
dissolved and denatured at 80°C for 10 min followed by incubation for 30 min at 37°C 
and added to heat-denatured chromosome spreads where hybridization was carried 
out over night in a moist chamber at 37°C. After posthybridization washing (50% 
formamide, 2  x SSC at 42°C) and blocking with nonfat dry milk powder, the hybridi­
zed probe was detected with avidin-FITC (Vector Laboratories) followed by two 
amplification steps using rabbit-anti-FITC (Dako) and mouse-anti-rabbit FITC 
(Jackson Immunoresearch), chromosome spreads were mounted in antifade solution 
with blue dye DAPI.
RESULTS AND DISCUSSION 
Structure o f  the A B O  gene locus: A human PI library was screened using a PCR
probe based on two primers located in the immediate intron boundaries to exon VI 
yielding a product of 240 bp. A single clone DMPC-HFF#1-0529F4 was isolated
and Southern analysis with various oligonucleotides covering the 3’ and 5’ coding
sequence of the existing full length ABO cDNA indicated that the entire coding
sequence apart from the most 3’ sequence of the known last exon VII was included
in an « 20 kbp Bam HI fragment (not shown). The stru cture of the coding region of
exon VII is inferred from PCR-analysis of genomic DNA (6 ).
319
Vol. 206, No. 1, 1995 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ABO Exon/Intron Boundaries
I II III IV V
• • ' i
JK '14 Wl TT
•h
9
+ 1 
23 17 16 12 45
VII
225 amino acids
Exon Intron Exon
II
III
IV
V
VI
.....
L A
I G CTG GCC G
28
• • "€ . > W-- . Ì 1 n 4 it • . > '  s" M ' " -*> ,i
k  M V *  i  > — •  m ' M J i W I . m * . » ) ' »  , »
L F G 
TTG TTT GG
98
"Vt" fr*4* -I* 4é* + *’»' r ^ • " ---- '
’  •  I*  - ' M / *  '  ' •  • ' ^ Y T h  , » * '  • '  —  *  ,  . ,  r *  H * , — S y  > . . ^ w  —
G - F C 
GGG TTC TG
155
« _ * _ « _  '  —  "  -  T  / < r - .  i  r r ^  1 »> s  •
,  ■* - - r V * .  I . l l i  •  •  T *  - » - ^ I P U  ' •  * • - - —  • .*, .  n y m  • _ A - -  ' -  '  * . .  h * v »  t
L P R 
TTG CCA AG
203
■ p w . ’ j j i »  < i u -v n  ----------- » ■  »■ '- » ' 'v v o  . .  u ____________• • i . p . . j i
—» w  —-  « v i r v r i  ,<•*,* p f A  u  b . .  .
T P C 
ACA CCG TG
239
i* r  1 «‘i n *  i l mn f r" ' ^ .  1 ------------- 'V sM H
I K K  
ATC AAG AA
374
g t g a g t ---- t g t t t t c c a g
.  - *  4.  >  -
*. \ * m f .  " -■ *< •• •*  V *  — W - , , , ,  \  ' V I ,  M .  <» .  .<  »  , s  <• i  -  .  . - -  - ,  •«
g t a a g a ---------------------c t t t c t g c a g
» ii* .k-. -  y , r u w  *> > f >t u  i> < >  i n «  « r«
^ . t s ^  ^  . . . .  V S^ p. fc ^  « iX i —s — -»-»-v» «  « ,  ,  1 , 1  I «  - > * .  « v v * S < n ,  I
g t g a g t ---------------------c a t t c t g c a g
i * T T ' * » f ' ,.1( V / l  r r ^ | , k« J h _ w v w , i | > | n  W'/JJ • J-*—. "  •• ^  ■ • A . ,  ,v—«* ». — ^  ^
g t a t a a -----------------------------------g c g c t t g c a g
• • ■ K |  1 1  n r *  t ^ < a *
g t g a g t ---- c c a t g t g c a g
g t a a g t ---- t g c c t t g a a g
G I< P 
GA AAA CCA
29
I .  .  « j «  « J 'I I «
> M V » » 4 •« ' « W»
« Ì  l l >  '  I  > k*
k  .  .  .  * t  » » r t  H *  *  m -  ! •
M A 
C AT G GCT G
156
—  • T V  ">C '  '  ------  •----- —  T  > T » ** V . • •
M V 
G ATG GTC T
204
R K 
T AGG AAG G
240
Y V 
A TAC GTG G
375
II
Y G
T TAC GGG G III
99
IV
V
r.-N-rt«*'' .« > -^> ... v  sa*^  :< ^  « « « • -  •
VI
VII
Figure 1 . Genomic organization of human ABO locus. Diagramatic representation 
of exon organization of the protein coding sequences (shaded). All exon regions 
were located on a single Bam HI fragment of a PI clone and approximate intron 
sizes estimated by PCR are indicated where possible . Indicated are the exon size 
as coding amino acid number. Indicated by superscripts to the exon size are bases 
deviating from a mul timer of three.
A comparative Southern blot analysis between the cloned PI DNA and total 
human genomic DNA using a full length cDNA as probe gave identical/similar 
patterns (not shown). The PI clone was partially sequenced and sequences of the 
coding region and 50-150 bp of adjacent introns were obtained (Figs. 1  and 2 ). As 
only little information of the untranslated 5’ sequence of the ABO transcripts are
Furthermore the 5’ and 3’ borders of exon 1 and exon 7, respectively, are 
undetermined. All exon/intron boundaries identified conformed to the GT-AG 
concensus rule (8 ).
The entire coding region of the to-date identified ABO cDNA clones is 
covered by 7 exons where the two largest, VI and VII, encode 11%  of the full 
coding region and 91% of the coding region of the previously established
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5 '  -  GGCTCCGCGTCTGGTCTCGGCCTCCGCCTTCCGCCCGGCGGCCCTGGGGC -
- Exon I -
-  GTGAGTGCAGGCCTCGGCCCCGGGTGCCCGCGAGGAGCCGCTACCGCAGG -  3 '  
5 '  -  GGTGAGAGAAGGAGGGTGAGTGATGTGATTTTTCTACTCCTGTTTTCCAG -
-Exon II -
-  GTAAGACAC ATT T GAC CAT C GAGGC T GGCCTGGTTTGGG GAGAAGT GAC C -  3 '  
5 '  -  AGGCAGTCTTCGTTCTGTGTCCTGAGTCTTGGCACACTTCCTTTCTGCAG -
- Exon III -
-  GTGAGTGCAGGGAAGAGCAGGTGGAGCATCCATGCTGGCCGGGGTGCTGG -  3 '
5 '  -  TAAATCCTGCTCCTAGACTAAACTTCATCTCCTGTGTTCTCATTCTGCAG -
- Exon IV -
-  GTATAATGTCAGTGCCTCCCTTCAGTGGCTCCCATGTCACAGAATTGTCC -  3 '
5 '  -  TGCATCCACGCTTTCCATGCAAACTCACGTGGCGCGCTTTGCGCTTGCAG -
- Exon V -
-  GTGAGTAAAGTTACTGACACTGAAACTGAACGCAGCTCAAGGGGCTGTTC -  3 '
5 '  -  GGTGGCACCCTGCCAGCTCCATGTGACCGCACGCCTCTCTCCATGTGCAG -
- Exon VI -
-  GT AAGT CAGT GAGGT GGC CGAGGGT AGAGAC C C AGGC AGTGGC GAGT GAC -  3 '
5 '  -  AGGGGTGCACGGCCGGCGGCTCCCCCAGCCCCCGTCCGCCTGCCTTGCAG -
- Exon VII -
-  GCGGCTGCCAGGGGCTCTGGGAGGGCTGCCGGCAGCCCCGTCCCCCTCCC -  3 '
Figure 2. Flanking untranslated sequences of exon /  and VÌI and flanking intron 
sequences of exon I I-VI.
catalytically active, soluble transferase protein. As shown in Table I, a PCR 
generated cDNA clone initiated at nucleotide position 115 (amino acid position 39) 
in exon III and including the entire 3’ coding sequence resulted in a catalytically 
active protein when expressed in the baculovirus system. This is in good agreement
with the observed amino-terminal sequence of purified soluble transferase protein 
from human lung (4) and intestinal mucosa (9).
Table I. Expression of soluble A transferase in Sf9 cells
Construct Specific activity
ti nits*/ml
If ..........................m u « « ............
Uninfected cells 0.00005
A enzyme sol.-l 0.0054
A enzyme sol.-2 0.
GalNAc-T2 soil 0.00010
* One unit defined as amount of enzyme transferring 
1 |imol GalNAc from UDP-GalNAc in 1 min using 
2 -fucosyllactose as acceptor.
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Studies of the histo-blood group ABO polymorphism, especially of rare sub­
groups, have generally been limited to the coding region covered by exon VI and 
VII, as these could be analysed by PCR amplification of genomic DNA (6 ). The 
difficulties in obtaining RNA for these studies make it valuable to be able to PCR 
amplify each of the coding exons separately using primers located in adjacent 
introns for subsequent sequence analysis. Figure 2  presents the immediate 50 bp 5
and 3’ intron sequences adjacent to exons, as well as 50 bp untranslated sequences 
5’ to exon I and 3’ to exon VII. Studies of the molecular genetic basis of the blood 
group ABO subgroups have indicated that structural changes in exon VI and VII 
result in the observed blood group phenotype. However, limiting the analysis to 
exon VI and VII of the rare blood group subgroups A3 and B3 failed to provide a 
basis for these phenotypes and it is thus likely that analysis of the 5 end will show 
changes leading to the observed phenotype (10). Although the catalytic domain of 
the A/B glycosyltransferases appears mainly to be encoded by exon VI and VII, it 
is possible that changes more 5’ in the gene may result in expression failure or 
changes in catalytic activity.
Com parison o f  genom ic structure o f  A B O  and al,3-galactosyltransferase: The human 
ABO genes show considerable homology with the bovine/murine a 1,3- 
galactosyltransferase as well as human processed pseudogenes hereof (11-13). As 
pointed out by Joziasse (14) the homology is limited to the last two coding exons in 
both the ABO gene (exon VI and VII) and the murine al,3-galactosyltransferase 
gene (exon VIII and IX) and the sequence homology as well as same exon sizes 
suggest an evolutionary relationship based on exon-shuffling. The intron/exon 
structure in the remaining 5’ part of the ABO locus shows similarity to that of the 
murine where 5, respectively 4, small exons code for the amino-terminal sequence. 
Interestingly, a similar structure in the reading frame of exons is also found. The 
ABO gene has a single base excess in the first two small exons (I and II), and the 
intervening exons III-VI are perfect multimers of three, whereas the last coding 
exon has a single base excess (Fig. 1 ). The bovine al,3-galactosyl transferase shows 
the same pattern only deviating by having one coding exon less and thus two excess 
bases in the first coding exon (exon IV) ( 1 1 ). Alternative splicing of the ABO genes 
may thus exclude exons III-VI without changes in reading frame. RT-PCR using 
primers located in exon I and VII gave rise to varying product sizes in different 
human organs, thus indicating that transcripts with alternative exon usage are found 
in different organs (Fig. 3). Subcloning and sequencing of several of these PCR 
products verified the transcript structures indicated in Fig. 3. To what extent such
322
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Figure 3. RT-PCR analysis of ABO gene transcripts in human organs. Panel A: RT- 
PCR products probed with exon VII specific probe. Panel B: Schematic 
representation of RT-PCR analysis of testis transcripts.
alternative transcripts are translated and enzymatically active will be the focus of 
future research. The finding of transcripts missing only exon VI is interesting as this 
contains the blood group O 1 frameshift mutation. A transcript lacking exclusively 
exon VI will introduce a stop codon and thus an enzymatically inactive truncated 
protein. Interestingly, Joziasse et al. ( 1 1 ) found no transcripts lacking this exon with 
the murine al,3-galactosyltransferase. It seems clear from studies of truncated 
forms of the al,3-galactosyltransferase that the protein sequence of both exon 8  
and 9 corresponding to VI and VII in the ABO gene is necessary for transferase 
activity (15).
Chromosomal localization o f  A B O  locus: Fluorescent in situ hybridization to 
metaphase chromosomes using the isolated PI phage showed fluorescence signals at 
9q34 (Fig. 4; 20 metaphases evaluated). No specific hybridization was observed at 
any other chromosomal site. This is in agreement with reported linkage analysis 
studies (16). Most of the glycosyltransferase genes for which a chromosomal 
localization has been established have shown that these are distributed all over the 
genome (14,17). Two processed pseudo-genes showing homology to a 1-3-
323
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Figure 4. Localization of the DMPC-HFF#1-0529F4 probe on 9q34 using 
fluorescence in situ hybridization (right panel, arrow). The identification of individual 
chromosomes was deduced from converted DAPI banding patterns (left panel).
galactosyltransferase and ABO gene are located on chromosome 12ql4-ql5 and 
9q33-q34 (15), thus at least one co-localizes with the ABO locus.
The structure of the ABO locus reported here should enable more detailed 
studies on the polymorphism involved in rare ABO blood groups. The reported 
intron sequences will allow PCR strategies for complete analysis of the coding 
region of the ABO locus using readily available genomic DNA. The isolation of a 
PI clone covering at least the entire 5’ coding region of the ABO locus will enable 
studies of the promoter region.
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